Recent Patents on Anti-Cancer Drug Discovery


Khurshid Zaman  
Bentham Science Publishers


Become EABM
Become Reviewer

Most Cited Article

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy promotion: free to download

Volume:13   Issue:1
Pp: 86-105
Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*
DOI: 10.2174/1574892812666171108124218

Advances in the Discovery of Anthraquinone-Based Anticancer Agents

Volume:13   Issue:2
Pp: 159-183
Alexander S. Tikhomirov*, Alexander A. Shtil and Andrey E. Shchekotikhin
DOI: 10.2174/1574892813666171206123114

PARP Inhibitors in Ovarian Cancer

Volume:13   Issue:4
Pp: 392-410
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*
DOI: 10.2174/1574892813666180305165256

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins open access plus

Volume:13   Issue:2
Pp: 184-200
Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*
DOI: 10.2174/1574892812666171129141211

Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy promotion: free to download

Volume:13   Issue:1
Pp: 2-17
Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*
DOI: 10.2174/1574892812666171030163804

The Application of lncRNAs in Cancer Treatment and Diagnosis

Volume:13   Issue:3
Pp: 292-301
Yi Zhang and Liling Tang*
DOI: 10.2174/1574892813666180226121819

Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies

Volume:13   Issue:2
Pp: 224-239
Monireh Mohsenzadegan*, Farhad Seif, Mohammad M. Farajollahi and Majid Khoshmirsafa
DOI: 10.2174/1574892813666180213164700

PARP Inhibitors in Epithelial Ovarian Cancer open access plus

Volume:13   Issue:2
Pp: 145-158
Kristin N. Taylor and Ramez N. Eskander*
DOI: 10.2174/1574892813666171204094822

Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature promotion: free to download

Volume:13   Issue:1
Pp: 40-69
Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves
DOI: 10.2174/1574892812666171108115959

Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied open access plus

Volume:13   Issue:2
Pp: 201-208
Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi
DOI: 10.2174/1574892813666180220110729

NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents promotion: free to download

Volume:13   Issue:1
Pp: 106-117
Spandana R. Kopalli , Tae-Bong Kang , Kwang-Ho Lee and Sushruta Koppula*
DOI: 10.2174/1574892812666171027102627

Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches promotion: free to download

Volume:13   Issue:1
Pp: 70-85
Viral Shah* and Pratiksha Kochar
DOI: 10.2174/1574892812666171129142023

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

Volume:14   Issue:2
Pp: 113-132
Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*
DOI: 10.2174/1574892814666190514104035

Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents open access plus

Volume:14   Issue:1
Pp: 5-18
Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*
DOI: 10.2174/1574892814666190116111827

Synthesis and DFT Study on Hantzsch Reaction to Produce Asymmetrical Compounds of 1,4-Dihydropyridine Derivatives for P-Glycoprotein Inhibition as Anticancer Agent

Volume:13   Issue:2
Pp: 255-264
Shirin Mollazadeh, Fatemeh Moosavi, Farzin Hadizadeh*, Mahmoud Seifi, Javad Behravan and Maryam Iman*
DOI: 10.2174/1574892813666180220112613

Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation open access plus

Volume:13   Issue:2
Pp: 133-144
Juan F. Santibanez* and Suncica Bjelica
DOI: 10.2174/1574892813666180220105958

The Epithelial-Mesenchymal Transition Pathway in Two Cases with Gastric Metastasis Originating from Breast Carcinoma, One with a Metachronous Primary Gastric Cancer promotion: free to download

Volume:13   Issue:1
Pp: 118-124
Simona Gurzu*, Laura Banias*, Tivadar Bara, Feher I, Tivadar Jr. Bara and Ioan Jung
DOI: 10.2174/2212798409666171101121108

Recent Progress of Marine Polypeptides as Anticancer Agents

Volume:13   Issue:4
Pp: 445-454
Lanhong Zheng, Yixin Xu, Xiukun Lin*, Zhixin Yuan, Minghua Liu, Shousong Cao, Fuming Zhang and Robert J. Linhardt
DOI: 10.2174/1574892813666180430110033

Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options open access plus

Volume:13   Issue:2
Pp: 209-223
Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*
DOI: 10.2174/1574892813666180115151554

Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease open access plus

Volume:14   Issue:2
Pp: 144-157
Dongmei Chen, Xiao Z. Zhou* and Tae H. Lee*
DOI: 10.2174/1574892814666181218170257

Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds open access plus

Volume:14   Issue:1
Pp: 19-31
Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*
DOI: 10.2174/1574892814666190111104834

New Anti-Cancer Strategies in Testicular Germ Cell Tumors open access plus

Volume:14   Issue:1
Pp: 53-59
Paolo Chieffi*, Marco De Martino and Francesco Esposito
DOI: 10.2174/1574892814666190111120023

Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors open access plus

Volume:13   Issue:4
Pp: 428-444
Zsuzsanna Suba*
DOI: 10.2174/1574892813666180720123732

Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature open access plus

Volume:13   Issue:4
Pp: 422-427
Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*
DOI: 10.2174/1574892813666180528105023